These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 5474598

  • 1. [The value of lipavlon in diabetic retinopathy].
    François P, Belervacque A, Turut P.
    Bull Soc Ophtalmol Fr; 1970 Apr; 70(4):568-73. PubMed ID: 5474598
    [No Abstract] [Full Text] [Related]

  • 2. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM, Attia O, Nabih AE, Nassar I, Ibrahim WN.
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract] [Full Text] [Related]

  • 3. Diabetic retinopathy.
    Harrold BP.
    Lancet; 1971 Jan 02; 1(7688):42. PubMed ID: 4099348
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A double-blind controlled trial of clofibrate in the treatment of diabetic retinopathy.
    Harrold BP, Marmion VJ, Gough KR.
    Diabetes; 1969 May 02; 18(5):285-91. PubMed ID: 4894161
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML, Setty KR, Roy SB.
    J Assoc Physicians India; 1971 Feb 02; 19(2):123-9. PubMed ID: 4934418
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical study of the effect of ethyl-alpha-p-chlorophenoxybutyrate (clofibrate) in the venous retinal thrombosis].
    Cioli S, Nizzola GM.
    Ann Ottalmol Clin Ocul; 1970 Sep 02; 96(9):477-82. PubMed ID: 5519038
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
    Noleto PA, de Bulhões F, Tuma M.
    Rev Bras Med; 1969 Oct 02; 26(10):602-5. PubMed ID: 5404870
    [No Abstract] [Full Text] [Related]

  • 10. [Serum-lipid reducing principles--possibilities for treatment. 6. Indications for the use of clofibrate].
    Gustafson A.
    Lakartidningen; 1970 Dec 14; 67():Suppl IV:75+. PubMed ID: 5511954
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of diabetes insipidus with clofibrate].
    Annee Endocrinol; 1971 Dec 14; 23():101-3. PubMed ID: 5562226
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The treatment of exudative diabetic retinopathies with clofibrate (Atromid-S)].
    Houtsmuller AJ.
    Ned Tijdschr Geneeskd; 1967 Nov 11; 111(45):2039-40. PubMed ID: 4863523
    [No Abstract] [Full Text] [Related]

  • 14. [Therapeutic study of clofibrate during pituitrin-sensitive diabetes insipidus in children].
    de Gennes JL, Desbois JC, Marie J.
    Ann Pediatr (Paris); 1970 Nov 02; 17(11):754-9. PubMed ID: 5484620
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
    Cullen JF, Ireland JT, Oliver MF.
    Trans Ophthalmol Soc U K (1962); 1964 Nov 02; 84():281-95. PubMed ID: 5227423
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A comparison of fenofibrate and clofibrate hypolipidemic effects.
    Daubresse JC.
    Acta Clin Belg; 1980 Nov 02; 35(4):227-32. PubMed ID: 7015771
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.